Ownership history in DRW Securities, LLC · 8 quarters on record
This page tracks every 13F SEC filing in which DRW Securities, LLC reported a position in ARRAY BIOPHARMA INC (ARRY). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 25,074 | +14,318 | +133.1% | 0.00% | $204K | $8.15 |
| 2025 Q2 | REDUCED | 10,756 | -209,340 | -95.1% | 0.00% | $63K | $5.90 |
| 2024 Q3 | ADDED | 220,096 | +70,096 | +46.7% | 0.04% | $1.5M | $6.60 |
| 2024 Q1 | ADDED | 150,000 | +143,800 | +2319.4% | 0.06% | $2.2M | $14.91 |
| 2019 Q2 | REDUCED | 6,200 | -3,800 | -38.0% | 0.02% | $287K | — |
| 2018 Q1 | REDUCED | 10,000 | -5,000 | -33.3% | 0.01% | $163K | — |
| 2017 Q4 | REDUCED | 15,000 | -5,000 | -25.0% | 0.02% | $192K | — |
| 2017 Q3 | INITIATED | 20,000 | — | — | 0.08% | $246K | — |
As of 2025 Q4 — sorted by position size